HSE weighs Mounjaro drug subsidy as experts urge food policy reform

The Health Service Executive is weighing a proposal to make the obesity drug Mounjaro free or at a reduced cost for up to a million eligible patients, potentially costing the Irish state up to three billion euros.

The Three Billion Euro Drug Proposal and Patient Eligibility

Negotiations led by Professor Michael Barry of the National Centre for Pharmacoeconomics resulted in significant price reductions for Mounjaro, bringing the medication close to cost-effective thresholds. However, patients hoping to access the drug through the HSE scheme must wait while health officials evaluate whether to supply it free via medical cards or at subsidized rates. A HSE Drugs Group spokeswoman indicated that several meetings remain necessary before any final recommendation reaches HSE management.

Proponents argue that despite the high upfront price tag, treating chronic conditions early prevents costly interventions down the line, such as joint replacements and advanced diabetes care.

Global Health Warnings on Unchecked Commercial Food Influence

While the pharmaceutical intervention advances, public health experts question the lack of parallel measures targeting the retail food environment. Dr Catherine Conlon pointed out in a letter that current state policies offer little beyond the hot school dinners programme to address the root causes of rising obesity rates, asking whether politicians have the gumption to challenge food giants.

The Lancet Commission on 21st Century Global Threats to Health identified obesity as the largest preventable health loss across 154 of 204 countries, projecting over 23 billion years of healthy life at stake by 2100. Kent Buse, professor of health policy at Monash University and co-chair of the World Obesity Federation’s Policy and Obesity Prevention Committee, noted that modeling shows scaling GLP-1 medicines to half of eligible populations yields only a small population-level impact compared with modifying food, transport, and physical activity environments.

Legislative Interventions and Tax Strategies in Global Markets

Several countries demonstrate that regulatory policies can alter consumption patterns when shielded from commercial opposition. Chilean legislation enacted in 2016 introduced front-of-pack warning labels, marketing restrictions directed at children, and school sales bans, successfully cutting sugar drink purchases by nearly a quarter against expected trends.

Colombia implemented an ultra-processed food tax that reduced national consumption by 4.3 percent within a year. In Ireland, a sugar-sweetened drinks tax introduced in 2018 triggered a 30.2 percent drop in retail soft drink sugar consumption and prompted four out of five leading brands to reformulate their recipes below tax thresholds. Following a 2024 evaluation of those figures, The Irish Heart Foundation urged authorities to expand the tax to all high-sugar foods.

Unresolved Questions on Food Regulation and State Spending

Prof Buse argued that relying on individual behavior change fails, asserting that government intervention in food systems is essential despite intense industry lobbying and litigation. The central unresolved question facing policymakers remains whether the state will deploy regulatory levers against commercial interests or continue relying primarily on pharmaceutical spending to manage a largely preventable public health crisis.